Ashland Global Hlds

Ashland, Inc. engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. It operates through the following segments: Life Sciences, Personal Care, Special Additives, and Intermediates. The company was founded in 1924 and is headquartered in Wilmington, DE.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Ashland Global Hlds reports solid Q1 performance amidst regional challenges

Ashland Global Hlds' Q1 earnings call highlighted a mix of strong performance, challenges in certain regions, and opportunities for growth through strategic initiatives. The company's focus on enhancing shareholder value, addressing market uncertainties, and driving innovation positions it for future success.

Ashland Global Hlds faces Q2 challenges, eyes pharma growth

Ashland Global Hlds faced challenges in Q2 2023 from global uncertainties and destocking, impacting margins and earnings, while showing strength in the pharma and Life Sciences segments.
The company's strategic focus on M&A in growth areas and ending destocking actions in key segments present opportunities for revenue growth and value creation.
Despite challenges, Ashland's performance reflects resilience and strategic decision-making, with a positive outlook for cash flow improvement and long-term growth.
Investors should monitor the company's progress in addressing challenges, leveraging strengths, and capitalizing on opportunities to drive sustainable financial performance.

Ashland Global Hlds faces destocking challenges but emphasizes resilience and growth

Ashland Global Hlds faced challenges from customer destocking, leading to a decline in sales and adjusted EBITDA, but demonstrated resilience and strength in managing mix improvements and margins.
The company remains focused on innovation, growth opportunities, and market confidence, with investments in core assets and new technologies continuing despite market challenges.
Opportunities lie in new product initiatives, global expansion, and capacity additions in key technologies, positioning Ashland Global Hlds for future growth and success.
Despite short-term challenges, Ashland Global Hlds maintains a strategic outlook, emphasizing long-term strategies, market confidence, and a commitment to driving growth through innovation.

Ashland Global Hlds faces challenges but targets growth opportunities

Ashland Global Hlds faced challenges in Q4 and anticipates uncertainties in 2024 but remains focused on long-term growth opportunities.
The company is optimizing its portfolio, targeting new growth drivers, and managing costs effectively to navigate current market conditions.
Despite near-term challenges, Ashland is resilient and committed to maximizing upside potential while minimizing downside risks.
Management's emphasis on proactive inventory control, cost management, and strategic priorities underscores their commitment to long-term success.

Ashland Global Hlds reports mixed Q1 results, focuses on long-term growth

Ashland Global Hlds reported mixed Q1 results with sales decline and EBITDA decrease, focusing on long-term growth strategies and shareholder value creation.
Challenges include lower demand in key units, compensation adjustments, market dynamics, and cost management considerations, while opportunities lie in M&A, innovation, and market expansion.
Stability in certain business segments and strategic initiatives to optimize operations provide a foundation for future growth and profitability amidst current challenges.
Overall, Ashland's performance reflects a balancing act between short-term setbacks and long-term strategic positioning for sustainable growth and market competitiveness.

Ashland Global Hlds beats Q2 expectations, eyes growth opportunities

Ashland Global Hlds demonstrated resilience in Q2 2024, exceeding EBITDA outlook and focusing on strategic growth.
Despite challenges in pricing and market dynamics, the company maintains a strong financial position and growth focus.
Opportunities lie in innovation, segment growth, and EBITDA normalization above 2021 levels.
The company's performance reflects a balance of challenges, strengths, and a proactive approach to future growth.

Ashland reports solid Q4 results, eyes global growth opportunities

Ashland Global Hlds (ASH) delivered a resilient performance in Q4 2024, with sales and adjusted EBITDA showing positive growth trends.
Strategic priorities for fiscal year 2025 aim to address challenges, capitalize on opportunities, and drive profitable growth for the company.
Despite near-term uncertainties, Ashland remains optimistic about its long-term prospects and ability to navigate evolving market conditions.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Ashland, Inc. engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. It operates through the following segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment is involved in pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. The Personal Care segment consists of biofunctionals, microbial protectants, skin care, sun care, oral care, hair care, and household solutions. The Specialty Additives segment focuses on rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive, and various industrial markets. The Intermediates segment refers to production of 1,4 butanediol and related derivatives, including n-methylpyrrolidone. The company was founded in 1924 and is headquartered in Wilmington, DE.

WILMINGTON, Del., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) has been recognized with the Commitment to Life Award in the Human Rights category by Natura&Co for Ashland's Responsible Solvers™ sustainable guar farming and education program using science, technology, engineering, and math (STEM) to train men and women farmers in Rajasthan, India.

Ashland recognized with Commitment to Life Award by Natura&Co

WILMINGTON, Del., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) has earned EcoVadis Gold underscoring the company's commitment to environment, social and governance (ESG) and a conscious-to-cutting-edge approach to innovation.

Ashland earns EcoVadis Gold

WILMINGTON, Del., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced the United States Food and Drug Administration (FDA) Center for Drug Evaluation and Research Office of New Drugs has accepted Ashland Viatel™ bioresorbable mPEG-PDLLA pharmaceutical excipient in the review cycle of the FDA Novel Excipient Review Pilot Program.

Ashland injectable pharmaceutical excipient accepted into FDA Novel Excipient Review Pilot Program

WILMINGTON, Del., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its fourth-quarter earnings release at approximately 5 p.m. ET on Monday, November 7, 2022. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Tuesday, November 8, 2022. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com .

Ashland sets date for fiscal 2022 fourth-quarter earnings release and conference call webcast

WILMINGTON, Del., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Effective October 1, 2022, Ashland Inc. (NYSE: ASH) will increase prices up to 15 percent or as contracts allow, to cover continued general inflation related to raw materials, energy, freight, and labor. The price increase includes all Ashland products across all the markets and applications the company serves including life sciences, personal care, specialty additives and intermediates.

Ashland increases prices up to 15 percent due to inflation-related costs

Wilmington, Del., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Ashland has announced a strategically significant expansion of its Viatel™ bioresorbable polymer manufacturing and research and development site at the National Science Park, home to a network of innovative organizations, in Mullingar, Ireland.

Ashland announces expansion of Viatel™ bioresorbable polymers manufacturing and R&D capabilities in Mullingar, Ireland

Ashland (ASH) benefits from strong demand in its end markets and its pricing actions to counter inflation.

Ashland (ASH) Shares Up 17% in 6 Months: What's Driving It?

The story of Ashland is one of a conglomerate shedding waste. While Ashland's financial data may suggest weak performance over a longer timeframe, the past four quarters may highlight a new trend.

Ashland: A Case Study In Conglomerate Revitalization

Ashland (ASH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Will Ashland (ASH) Gain on Rising Earnings Estimates?

Ashland proceeds will fund environmental trust Ashland proceeds will fund environmental trust

Ashland completes sale of land located in Ajax, Canada to Sunray Group of Hotels Inc, for CAD $12.25 million

Ashland Global Holdings Inc. (NYSE:ASH ) Q3 2022 Earnings Conference Call July 27, 2022 9:00 AM ET Company Participants Seth Mrozek - Director, IR Guillermo Novo - Chairman and CEO John Willis - SVP and CFO Conference Call Participants Christopher Parkinson - Mizuho Joshua Spector - UBS John McNulty - BMO Capital Markets David Begleiter - Deutsche Bank Mike Harrison - Seaport Research Partners Michael Sison - Wells Fargo Operator Thank you for standing by. Welcome to the Ashland Global Holdings Inc. Third Quarter 2022 Earnings Call.

Ashland Global Holdings Inc. (ASH) CEO Guillermo Novo on Q3 2022 - Earnings Call Transcript

Ashland's (ASH) Q3 sales were driven by disciplined pricing actions, strong demand and better product mix.

Ashland's (ASH) Earnings and Sales Surpass Estimates in Q3

Ashland (ASH) delivered earnings and revenue surprises of 0.53% and 0.02%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Ashland (ASH) Tops Q3 Earnings and Revenue Estimates

WILMINGTON, Del., July 26, 2022 (GLOBE NEWSWIRE) -- Ashland Global Holdings Inc. (NYSE: ASH) today announced financial results1 for the third quarter of fiscal year 2022, which ended June 30, 2022. The global additives and specialty ingredients company holds leadership positions in high-quality, consumer-focused markets including pharmaceuticals, personal care and architectural coatings.

Ashland reports strong financial results1 for third quarter of fiscal year 2022 consistent with previous update

WILMINGTON, Del., July 20, 2022 (GLOBE NEWSWIRE) -- Ashland Global Holdings Inc. (NYSE: ASH) today announced plans to change its legal name from “Ashland Global Holdings Inc.” to “Ashland Inc.” effective as of August 1, 2022, subject to satisfying all applicable legal requirements. The name change will be the final step of an internal reorganization to simplify the company's legal entity structure, which will see Ashland LLC (a wholly owned, indirect subsidiary of the company) merging into its direct parent Ashland Chemco Inc. (a wholly owned, direct subsidiary of the company), which will immediately thereafter merge directly with and into the company.

Ashland Global Holdings Inc. changes name to Ashland Inc.

Ashland (ASH) projects adjusted earnings from continuing operations for the fiscal third quarter of roughly $104 million or $1.89 per share.

Ashland (ASH) Issues Fiscal Q3 Update, Raises FY22 Outlook

Ashland (ASH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ashland (ASH) Earnings Expected to Grow: Should You Buy?

WILMINGTON, Del., July 18, 2022 (GLOBE NEWSWIRE) -- Ashland Global Holdings Inc. (NYSE: ASH) today provided an update for preliminary fiscal 2022 third-quarter financial results1 and raised its outlook for fiscal year 2022 results. Additional information regarding third-quarter fiscal 2022 earnings and full-year outlook will be shared during a conference call webcast with securities analysts on Wednesday, July 27, 2022.

Ashland provides update on fiscal 2022 third-quarter earnings and raises its financial outlook for fiscal year 2022; sets date for fiscal 2022 third-quarter earnings release

Ashland (ASH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Can Ashland (ASH) Keep the Earnings Surprise Streak Alive?

Ashland (ASH) benefits from strong demand in most consumer end markets and its pricing actions to counter inflation.

What Makes Ashland (ASH) Stock a Solid Choice Right Now

Ashland completes sale of Section 1 Hercules Redevelopment Plan for land located in Sayreville, NJ to Parlin Section 1 Urban Renewal, LLC for $40 million

Ashland (ASH) gains on solid demand in most consumer end markets and its pricing and mix improvement actions to counter cost inflation.

Ashland (ASH) Benefits From Strong End-Market Demand & Pricing

William G. Dempsey and Ricky C. Sandler plan exit in January 2023 William G. Dempsey and Ricky C. Sandler plan exit in January 2023

Ashland Board appoints Steve D. Bishop, former chief executive officer, Procter and Gamble consumer health care, and Suzan F.

Ashland (ASH) gains on strong demand and its pricing and mix improvement actions to counter inflation.

Here's Why You Should Add Ashland (ASH) Stock to Your Portfolio

Ashland's (ASH) latest addition, Gafchromic LD-V1 film includes improved contrast and imaging detail.

News for Ashland Global Hlds Stock (ASH)